Kind methods mean happy cells

Stem cells from umbilical cords in Skåne are improved with nanotubes. By cross-pollinating nanotechnology with stem cell biology, researchers are creating gentle methods to ensure that more cells perform better. Blood stem ...

Making CRISPR hype more of a reality

This year, we celebrate 10 years of genome editing with CRISPR. The system is often referred to as molecular scissors, and this designation is quite accurate for its first applications. These short 10 years were marked by ...

CRISPR: a tool to rewrite the code of life

CRISPR-Cas9, the gene-editing technique whose twin founders were honoured with the Chemistry Nobel on Wednesday, is a tool that can change the DNA of animals, plants and microorganisms with extreme precision.

Lethal Atlantic Virus found in Pacific Salmon

The highly contagious marine influenza virus, Infectious Salmon Anaemia (ISA) has for the first time been officially reported after being found in the Pacific on B.C.’s central coast.

page 1 from 2

Anemia

Anemia ( /əˈniːmiə/; also spelled anaemia and anæmia; from Greek ἀναιμία anaimia, meaning lack of blood) is a decrease in number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency.

Because hemoglobin (found inside RBCs) normally carries oxygen from the lungs to the tissues, anemia leads to hypoxia (lack of oxygen) in organs. Because all human cells depend on oxygen for survival, varying degrees of anemia can have a wide range of clinical consequences.

Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis).

There are two major approaches: the "kinetic" approach which involves evaluating production, destruction and loss, and the "morphologic" approach which groups anemia by red blood cell size. The morphologic approach uses a quickly available and low cost lab test as its starting point (the MCV). On the other hand, focusing early on the question of production may allow the clinician to expose cases more rapidly where multiple causes of anemia coexist.

This text uses material from Wikipedia, licensed under CC BY-SA